Skip to content

Regenxbio RGNX Cash Flow Statement

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
-$90.05M-34.1%-$67.15M-8.4%-$61.94M+12.6%-$70.87M-1,265%$6.08M+112%
$3.86M-0.3%$3.87M-0.4%$3.89M-0.5%$3.91M-1.3%$3.96M-1.7%
$8.62M+2.9%$8.38M-6.9%$9M+4.0%$8.65M+1.4%$8.54M-10.5%
-$76.19M-45.7%-$52.29M+6.6%-$55.96M-13.4%-$49.34M-247%$33.63M+206%
$1.24M+143%$508K+3.5%$491K+25.6%$391K-61.8%$1.02M-5.1%
$70.59M-$140.44M-414%$44.74M+11.1%
-$13.64M$139.23M+2,503%-$5.79M
-$19.24M+21.0%-$24.34M$72.58M+7,884%
-$77.42M-46.6%-$52.8M+6.5%-$56.45M-13.5%-$49.73M-253%$32.61M+200%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Regenxbio generate?
Regenxbio (RGNX) generated -$233.8M in operating cash flow over the trailing twelve months.
What is Regenxbio's free cash flow?
After $2.6M of capital expenditures, Regenxbio's free cash flow was -$236.4M over the trailing twelve months, down 171.9% year over year.
Where does Regenxbio's cash flow data come from?
Every line is extracted from Regenxbio's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.